Clinical trial
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
NCT00141063 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00141063 |
|---|---|
| Title | Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD |
| Official title | Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | ADHD |
| Intervention type | Drug |
| Interventions | Focalin XR |
| Enrollment | 90 |
| Start date | Jun 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Dec 21, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: